"But I can choose differently. I can go back."
She was back in the original lab. Tuesday. The foam. The humming.
The pipeline focuses on difficult-to-treat indications such as HER2-low breast cancer and extensive-stage small cell lung cancer (SCLC). Key Context from the Daiichi Sankyo Pipeline